# Stroke and Tocotrienol: Unique Role in Neuroprotection

Study · id `cardio:ct-nct02263924` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02263924](<https://clinicaltrials.gov/study/NCT02263924>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02263924

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

## Technical summary

Registry record NCT02263924. Randomized; quadruple masking; primary purpose treatment. Start 2015-07 (registry gives no type); primary completion 2018-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT02263924, source copy `cardio:ctgov-nct02263924-2018-02-13`, retrieved 2026-10-26)
- Start date: 2015-07 (registry gives no type) (ClinicalTrials.gov record NCT02263924, source copy `cardio:ctgov-nct02263924-2018-02-13`, retrieved 2026-10-26)
- Primary completion: 2018-12 (anticipated) (ClinicalTrials.gov record NCT02263924, source copy `cardio:ctgov-nct02263924-2018-02-13`, retrieved 2026-10-26)
- Completion: 2018-12 (anticipated) (ClinicalTrials.gov record NCT02263924, source copy `cardio:ctgov-nct02263924-2018-02-13`, retrieved 2026-10-26)
- Countries: Malaysia (ClinicalTrials.gov record NCT02263924, source copy `cardio:ctgov-nct02263924-2018-02-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02263924-2018-02-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Stroke and Tocotrienol: Unique Role in Neuroprotection
- Acronym: SATURN
- Condition: Ischemic Stroke
- Intervention (Dietary supplement): Tocotrienol
- Intervention (Dietary supplement): Placebo capsules
- Lead sponsor: Seberang Jaya Clinical Research Centre
- Lead sponsor class: OTHER\_GOV
- Collaborator: Clinical Research Centre Hospital Taiping
- Collaborator class: UNKNOWN
- Collaborator: Universiti Sains Malaysia
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as a collaborator: Universiti Sains Malaysia (`cardio:org-universiti-sains-malaysia`)

## Provenance

Content hash: e4730f6cb1d54947d921a92ca020b607a9b10d86a1e42eb1f5616c3b59afe19e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
